Bruno Loillier
Inventiva (France) · 13 works · 322 citations · h-index 10
Top works
- Pharmacological profile of LF 16-0687, a new potent non-peptide bradykinin B2 receptor antagonist
- Stable expression of human kinin B1 receptor in 293 cells: pharmacological and functional characterization
- Characterization of the molecular interactions of interleukin-8 (CXCL8), growth related oncogen α (CXCL1) and a non-peptide antagonist (SB 225002) with the human CXCR2
- Identification of a Key Region of Kinin B1 Receptor for High Affinity Binding of Peptide Antagonists
- LF 16.0335, a novel potent and selective nonpeptide antagonist of the human bradykinin B2 receptor
- Pharmacological characterization of the bradykinin B2 receptor: inter‐species variability and dissociation between binding and functional responses
- Haemodynamic and cardiac effects of kinin B1 and B2 receptor stimulation in conscious instrumented dogs
- Interleukin 8 (IL-8) Induces the Expression of Kinin B1Receptor in Human Lung Fibroblasts
- Cloning and characterization of guinea pig interleukin-8 receptor
- In vitro and in vivo effects of the new nonpeptide bradykinin B2receptor antagonist, LF 16‐0335C, on guinea‐pig and rat kinin receptors
- Erratum to “Characterization of the molecular interactions of interleukin-8 (CXCL8), growth related oncogen α (CXCL1) and a non-peptide antagonist (SB 225002) with the human CXCR2” [Biochem. Pharmacol. 65 (2003) 813–821]
- 594 Identification of novel EZH2 inhibitor scaffolds
- Abstract 4524: A rational approach for the discovery of inhibitors of NSD2 for the treatment of multiple myeloma